Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Goodwill & Intangibles (2019 - 2025)

Revolution Medicines has reported Goodwill & Intangibles over the past 7 years, most recently at $70.4 million for Q4 2025.

  • Quarterly results put Goodwill & Intangibles at $70.4 million for Q4 2025, down 1.22% from a year ago — trailing twelve months through Dec 2025 was $70.4 million (down 1.22% YoY), and the annual figure for FY2025 was $70.4 million, down 1.22%.
  • Goodwill & Intangibles for Q4 2025 was $70.4 million at Revolution Medicines, roughly flat from $70.5 million in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for RVMD hit a ceiling of $77.9 million in Q2 2021 and a floor of $70.4 million in Q1 2021.
  • Median Goodwill & Intangibles over the past 5 years was $73.3 million (2022), compared with a mean of $74.3 million.
  • Biggest five-year swings in Goodwill & Intangibles: rose 10.62% in 2021 and later fell 9.6% in 2023.
  • Revolution Medicines' Goodwill & Intangibles stood at $77.9 million in 2021, then dropped by 5.74% to $73.4 million in 2022, then fell by 1.45% to $72.3 million in 2023, then fell by 1.48% to $71.3 million in 2024, then dropped by 1.22% to $70.4 million in 2025.
  • The last three reported values for Goodwill & Intangibles were $70.4 million (Q4 2025), $70.5 million (Q3 2025), and $70.4 million (Q2 2025) per Business Quant data.